Who founded Telesis Bio?

Telesis Bio was founded by Daniel G. Gibson, Todd R. Nelson in 2013.

Who are Telesis Bio's investors?

Telesis Bio's investors include Novalis LifeSciences.

How much funding has Telesis Bio raised?

Telesis Bio has disclosed $28M raised across 1 round.

Where is Telesis Bio headquartered?

Telesis Bio is headquartered in San Diego, US.

Telesis Bio

San Diego, US · Founded 2013 · Delaware corporation · 42 employees on LinkedIn · 1 known investors

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.

AI & Machine Learning Biotech Deep Tech Hardware Healthtech

Founders & leadership

Telesis Bio was founded in 2013 by Daniel G. Gibson and Todd R. Nelson.

Daniel G. GibsonCo-founder

Todd R. NelsonCo-founder

Eric EsserExecutive

William F. SniderNamed on SEC filing

Andrea L. JacksonNamed on SEC filing

Christine A. TsingosNamed on SEC filing

Robert H. CutlerNamed on SEC filing

Annette V. TumoloNamed on SEC filing

Jami NachtsheimNamed on SEC filing

Board

Paul MeisterBoard directorPartner at Novalis LifeSciences

Franklin R. WitneyChair of the Board of Directors

Investors · 1

Novalis LifeSciencesPortsmouth

Reported raises · per SEC filings

Form D private placements

$28M disclosed across 1 round · 2023

▶$28MraisedJun 2023 · 4 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Franklin R. WitneyDirector
Eric EsserExecutive Officer
Paul MeisterDirector
William F. SniderDirector
Andrea L. JacksonDirector
Christine A. TsingosDirector
Robert H. CutlerExecutive Officer
Annette V. TumoloDirector
Jami NachtsheimDirector
Daniel G. GibsonExecutive Officer
Todd R. NelsonExecutive Officer, Director

Offering amount: $74.2M
Amount sold: $28M
Sales commissions: $850K
Placement agents: H.C. Wainwright & Co., LLC
First sale: Jun 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Twist Bioscience30 shared keywordsTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.

Companies competing with Telesis Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Telesis Bio do?: Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.
Who founded Telesis Bio?: Telesis Bio was founded by Daniel G. Gibson, Todd R. Nelson in 2013.
Who are Telesis Bio's investors?: Telesis Bio's investors include Novalis LifeSciences.
How much funding has Telesis Bio raised?: Telesis Bio has disclosed $28M raised across 1 round.
Where is Telesis Bio headquartered?: Telesis Bio is headquartered in San Diego, US.